| Autor: |
Plank PM; Hannover Medical School, Department of Cardiology, 30625 Hannover, Germany., Hinze CA; Hannover Medical School, Department of Respiratory Medicine, 30625 Hannover, Germany., Sedlacek L; Hannover Medical School, Institute of Medical Microbiology and Hospital Epidemiology, 30625 Hannover, Germany., Welte T; Hannover Medical School, Department of Respiratory Medicine, 30625 Hannover, Germany., Suhling H; Hannover Medical School, Department of Respiratory Medicine, 30625 Hannover, Germany., Gottlieb J; Hannover Medical School, Department of Respiratory Medicine, 30625 Hannover, Germany.; German Center for Lung Reasarch (DZL), Germany. |
| Abstrakt: |
Competing Interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Pia Maria Plank reports no conflict of interest. Christopher Alexander Hinze reports no conflict of interest. Sedlacek Ludwig reports no conflict of interest. Tobias Welte T.W. and/or his institution received grants advisory/lecture/clinical trial fees and non– financial support by DFG (German Research Council), BMBF (German Ministry of Research and Education), BMG (German Ministry of Health), EU, WHO, AstraZeneca, Basilea, Biotest, Bayer, Boehringer, Berlin Chemie, GSK, Infectopharm, MSD, Novartis, Pfizer, Roche, AstraZeneca, Basilea, Biotest, Bayer, Boehringer, Gilead, GSK, Janssen, Novartis, Pfizer, Roche, all outside the submitted work. Hendrik Suhling reports personal fees/speaker honoraria from Astrazeneca, GSK, Novartis, Sanofi, outside the submitted work. Jens Gottlieb reports institutional research grants from Zambon /Breath Therapeutics, German Center of Lung Research, Deutsche Forschungsgemeinschaft. He also received fees for advisory/consultancy from Theravance, Pierre Fabre, Precision, Atheneum, Merck, Springer Healthcare, European Research Network and speaker fees from Novartis, Astra Zeneca. |
